4DMedical has announced the appointment of its current Non-Executive Director and Chair of Audit & Risk Committee, Lil Bianchi, as Chair.

She succeeds Bruce Rathie, the outgoing Chair and Non-Executive Director who is set to retire.

4DMedical is a company specializing in healthcare services and equipment.

4DMedical (ASX:4DX) provides various healthcare services and is known for its wide range of medical equipment.

Australian gold stocks (ASX:AXGD) observed a rise of up to 4.3%, marking the lowest since mid-March.

If the current losses are maintained, AXGD is set to mark its worst day since the end of July.

Fallen bullion prices, driven by a robust dollar and possibilities of higher U.S.

interest rates, are influencing the sub-index’s performance.

Moreover, heavyweights of the sector such as Newcrest Mining (ASX:NCM) experienced over a 4.5% decline, reaching their lowest since the beginning of March.

Similarly, Northern Star Resources (ASX:NST) fell to its lowest level since late November, 2022, and Evolution Mining (ASX:EVN) went down by 5.2%, hitting its lowest level in half a year.

Despite these declines, the sub-index has seen a year-to-date gain of 6% as of last close.

The Australian Gold Stocks consists of shares in gold mining and production companies headquartered in Australia.

Analysts from Macquarie have increased the price target on Wesfarmers (ASX:WES), Australia’s retail giant, by 5.6% to A$57/share.

The expected earnings of the company have also been revised upwards, in the range of 5% to 7.2% for the financial years 2025 and 2026.

This upgrade results from higher sales and margins from its Bunnings chain.

Wesfarmers, with Bunnings as its ‘jewel in the crown’, owns one of Australia’s supreme retail assets.

However, the sales productivity of Bunnings remains lower than its U.S.

competitors, Home Depot and Lowe’s, indicating more upside potential, according to Macquarie.

The shares of Wesfarmers are currently down by 1%.

Wesfarmers (ASX:WES) is one of Australia’s largest retail companies, with a variety of business operations.

Pharmaxis shares experienced a significant increase of as much as 21.2%, reaching A$0.040, marking their highest level since September 7.

The company appears to be on track for its best day since November 2, 2020, if current gains persist.

Pharmaxis announced the sale of its mannitol respiratory business to pharmaceutical manufacturing specialist Arna Pharma, a significant move that has likely contributed to its stock rise.

The company also revealed that it would undergo a name change to Syntara, and it will be reducing its board size.

There were further changes on the board as current Chair Malcolm McComas announces his retirement, with Kathleen Metters stepping in to fill his position.

There has been a significant trading activity, with 451,753 shares changing hands, noticeably higher than the 30-day average volume of 400,496 shares.

Despite this recent success, the stock has still seen a decrease of 45.9% this year, as measured from the prior close.

Pharmaxis is a pharmaceutical company focusing on respiratory diseases.

Australia-based company, Galena Mining (ASX:G1A), experienced a surge in its share price, increasing as much as 2.0% to A$0.10 and hitting a record high since September 20.

The increase was fueled by the company’s announcement regarding its quarterly production.

The precious metals miner reported a total ore milled of 283,000 tonnes, a significant 49% increase from the previous quarter.

In addition to the robust production, the Abra Mine, owned by Galena, generated positive operating cash flows for the quarter ending September 30.

However, despite the recent surge, the company’s stock has fallen by 60% in value over the course of this year, considering the last close.

Galena Mining (ASX:G1A) is a mining company based in Australia, specializing in the extraction of precious metals.

Shares of XTEK saw an impressive uptrend, rising as much as 14.1% to A$0.365 - marking its biggest intraday percentage gain since May 22.

The defence industry company announced that it has won a new multi-year support contract from the Commonwealth of Australia’s Department of Defence.

Total contract value over the tenure of 10-years has the potential to exceed A$110 million ($69.95 million).

The new contract involves maintaining and sustaining a newly acquired mixed fleet of AeroVironment Small Unmanned Aerial Systems.

Today’s surge puts the stock at its highest level since September 4, even though it has fallen 47.5% year-to-date from its previous closing position.

XTEK is a defence industry company that deals with the Department of Defence.

RPMGlobal (ASX:RUL) shares surge up to 4.7% to A$1.565, marking their highest value since September 4.

The surge comes after the mining software solutions provider reports an increase in its total contracted value from software sales, which is now A$13.2 million, up from A$5.2 million the previous year.

The company’s revised outlook for the total revenue now falls within a range of A$107 million to A$112 million for the fiscal year 24, marking an increase from the earlier projected range of A$105 million to A$110 million.

Profit before tax for FY24 is expected between A$13.5 million to A$15 million, which is above the previous forecast of A$12.5 million to A$14 million.

Despite this positive outlook, the company’s stock is down by 14.6% year-to-date as of the last close.

RPMGlobal is a recognized provider of mining software solutions.

Analysts from Goldman Sachs have readjusted their price target on Australia’s Liontown Resources (ASX:LTR) to A$1.35 per share, down from A$1.40.

This action has resulted in a marginal slip of Liontown Resources' shares by roughly 0.7%.

Updated figures from last Friday indicate that Liontown Resources has raised its project capital cost estimate for the Kathleen Valley lithium project to A$951 million.

This adjustment comes up from the previous estimate of A$895 million.

The Kathleen Valley project, standing as one of the main assets of Liontown Resources, is located to the north-east of Perth.

An acquisition of Liontown Resources by Albemarle Corp is already in progress.

Notably, Liontown Resources' stock has more than doubled in value over the past year.

Liontown Resources is a notable player in the Australian market, primarily engaged in the exploration and production of lithium.

ECS Botanics (ASX:ECS) witnessed a surge in its shares by 40.9% to A$0.031, marking the biggest intraday percentage gain since December 8, 2020.

The medicinal cannabis company has secured a binding off-take agreement to supply medicinal cannabis dried flower for the next five years to Perth-based medicinal cannabis company, MediCann Health.

Under this deal, ECS Botanics (ASX:ECS) will provide A$24 million of pharmaceutical-grade cannabis dried flower to MediCann starting January 2024.

The shares reached their pinnacle since February 10, 2022.

Around 15.6 million shares traded hands in contrast with to the 30-day average of 1.4 million shares.

The stock of ECS (ASX:ECS) went up by 10% YTD at the clos of the last trading session.

ECS Botanics is a company specialized in the production and supply of medicinal-grade cannabis dried flower.

Shares of Computershare (ASX:CPU) see a significant surge of up to 3.3%, reaching A$26.66.

This marks their highest level since December 22.

The last recorded gain for the stock was 1.6%.

The company entered a definitive agreement to sell its U.S.

mortgage services business to Rithm Capital Corp for an estimated consideration of $720 million.

Computershare expects that the transaction will promote earnings per share (EPS), though it would not have a substantial impact on the financial year 2024 EPS guidance.

The completion of this transaction is scheduled for early Q4 in Financial Year 2024 and is expected to result in a one-off statutory pre-tax loss on the sale of roughly $150 million to $180 million.

Computershare’s stock has dropped by 1.5% this year as of the last closure.

Computershare (ASX:CPU) is a share registry firm.